Cipla Sustainability

Sustainability

Our approach to responsible resource consumption, efforts to enhance access and affordability of medicines worldwide and strong financial growth, provide a robust foundation to build a responsible business.

Sustainability Goals

By 2025

Cipla endeavours to be a Carbon Neutral, Water Neutral and Zero Waste to Landfill Company, to attain AMR Stewardship, Green Chemistry & Making it Right, Well-being of employees and partners.

By 2030

Cipla endeavours to be a Carbon Positive, Water Positive and AMR Compliant Company
7% Revenue CAGR over the last 5years
4.8% R&D Investment
₹ 19,160 Crores Revenue from Operations

Manufacturing Highlights

Our investments in manufacturing capital include development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments and strengthening of platform technologies.

 

33 billion
Tablets and capsules

 

132.30 million
Aerosol pMDI

 

11 million
Lyophilised injections

 

808 million
Repsules

 

52.30 million
Nasal sprays

 

84.20 million
Oral liquids

 

2.50 million
Form-fill seal eye-drops

 

 

COMMITTEES
OF BOARD
Learn More
MILESTONE
AWARDS
Learn More